Pasithea Therapeutics Corp.
KTTA
$0.7174
$0.00030.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.88% | 16.44% | 12.89% | 1.60% | 3.63% |
| Total Depreciation and Amortization | -0.18% | -0.09% | 0.09% | 32.38% | 97.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.38% | 75.30% | 171.47% | 134.06% | 320.70% |
| Change in Net Operating Assets | -201.11% | -127.31% | -196.52% | -128.87% | -88.34% |
| Cash from Operations | 16.30% | 11.86% | -3.71% | -6.10% | 7.14% |
| Capital Expenditure | -- | -- | -- | 100.00% | 114.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -0.91% | 198.18% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -28.23% | -100.00% |
| Cash from Investing | -- | -- | -- | 143.46% | 104.84% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 48.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 103,385.71% | -- | -- | -- |
| Cash from Financing | 403.93% | 249.99% | 221.23% | 165.50% | -25.61% |
| Foreign Exchange rate Adjustments | 240.43% | 9.52% | 37.50% | -120.79% | -108.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.98% | 62.76% | 43.85% | 55.15% | 12.09% |